Vancouver) and cytokine mix (FLT3 ligand 100 ng/mL; SCF 100 ng/mL; TPO 100 ng/mL; IL-6 20 ng/mL -all from Peprotech, Rocky Hill or ebioscience, San Diego).
Following expansion in the culture medium, cord blood cells were transduced with retrovirus by spinoculation. Seventy two hours following their transduction, the cells were stained with an APC-conjugated anti-CD34 antibody (Becton Dickinson, San Jose), and the GFP + /CD34 + cells were sorted using MoFlo. The cells were counted and replated weekly at a concentration of 1x10 5 /ml. To monitor erythroid differentiation, CD34 + cells were grown in IMDM/BIT with SCF 100 ng/ml and EPO 6 units/ml. To monitor myeloid differentiation, CD34 + cells were grown in IMDM/BIT with SCF 100 ng/ml, Flt3-L 10 ng/mL, IL-6 20 ng/ml, IL-3 20 ng/ml, GM-CSF 20 ng/mL and G-CSF 20 ng/mL.
Cobblestone area forming cell (CAFC) assay
To assay for stem cells using the CAFC assay, GFP + CD34 + cells were cocultured on an MS-5 monolayer in IMDM containing 12.5% FCS, 12.5% horse serum, 1 µM hydrocortisone, 4 mM L-glutamine, and 100 U/ml penicillin/streptomycin. The cultures were demidepopulated each week. After 5 weeks in culture, total cobblestone areas were counted.
Flow cytometry
To monitor CD34 expression, the cells were stained with an APC-conjugated anti-CD34
antibody (Becton Dickinson). To monitor Glycophorin A and CD71 expression, the cells were stained with a PE-conjugated anti-Glycophorin A antibody and an APC-conjugated anti-CD71 antibody (Beckman-Coulter). To monitor CD11b expression, the cells were stained with a PE-conjugated anti-CD11b antibody (Beckman-Coulter). To monitor C-kit, CD45 and CD45.2 expression, the cells were stained with the APC-conjugated anti-C-kit, the PE-conjugated anti-CD45 and the PE-conjugated anti-CD45.2 antibody (Becton Dickinson). Data were analyzed with Flowjo software using a Becton Dickinson FACSCalibur.
Microarray Analysis
RNA was isolated from human CD34 + cells expressing empty vector MIGR1, AML1-ETO or AML1-ETO∆NHR1(aa245-436) using the Qiagen RNeasy Plus® mini kit, transcribed into cDNA using random hexamer priming and Superscriptase (Invitrogen), and then hybridized to the Affymetrix HG-U133 GeneChips. The data were analyzed using Partek Genomic Suites, version 6.5 to identify differentially expressed genes. Triplicate samples were prepared independently for each condition. The following is the link to our microarray data.
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=zpqvjwieeqmycnu&acc=GSE283
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Real Time RT-PCR
The RNA extraction and cDNA generation procedures were described above. The reverse transcription reaction was performed for 10 min at 25°C, 50 min at 50°C, 5 min at 85°C
and 20 min at 37°C. Real-time quantitative PCR was performed using a TaqMan 7500 sequence detector system (Applied Biosystems). The thermal cycle conditions were:
50°C for 2 min, 95°C for 10 min to activate Amplitaq Gold DNA polymerase, denaturation at 95°C for 15 seconds and anneal/extension at 60°C for 1 min (45 cycles).
Quantitative PCR for HPRT was performed to normalize for cDNA loading. The relative quantification of gene expression was calculated using the method (2^-Ct ), as described by the manufacturer. PCR primer sequences are available upon request.
Luciferase reporter gene assay
To assess GM-CSF and IL-3 promoter activity, MLA144 cells were transfected with either a pGL3-GM-CSF or a pGL3-IL-3 promoter-luciferase construct, with pRL-SV40
Renilla luciferase plasmid, and either the empty pcDNA3 vector, pcDNA3-AML1b, pcDNA3-AML1-ETO or pcDNA3-AML1-ETO-∆NHR1(aa245-436) using the Amaxa electroporation nucleofector system (Amaxa Biosystems). Luciferase assays were carried out using the Dual-luciferase reporter assay system (Promega), and luminometric units were determined using the BioTek Synergy 2 plate reader (BioTek). To assess M-CSFR promoter activity, Hela cells were transiently transfected using the FuGene6 reagent (Roche). These transfections included the M-CSFR promoter-luciferase construct, the Renilla luciferase construct and pcDNA3/pcDNA3-AML1b and either MIGR1, MIGR1-AML1-ETO or MIGR1-AML1-ETO-∆NHR1 (aa245-436). Luciferase promoter assays were performed as described above, and Renilla luciferase activity used to normalize transfection efficiency.
Antibodies
Anti-p300 (Millipore or Santa Cruz), anti-Flag (Sigma), anti-HA (Santa Cruz), anti-ETO (generated in the Roeder lab or Santa Cruz), anti-AML1 (29), anti-acetylated lysine (Stressgen), anti-acetylated Histone H3 (Millipore), anti-Tubulin (Sigma), anti-TAFІІ250
(generated in the Roeder lab) and anti-TAF7 (generated in the Roeder lab) antibodies were used. We also generated two anti-acetylated AML1-ETO polyclonal antibodies by immunizing rabbits with the synthetic peptides (TALSPGK [acetylated] MSEA or LAGK
[acetylated] LRSGDRS) conjugated to KLH. The polyclonal antiserum was collected and purified using a peptide affinity column. The affinity of the antibodies against acetyllysine AML1-ETO was measured by dot blot assays. For the dot blot assays, we spotted 5 pmol of peptide (measured by Ellman's reagent) onto a nitrocellulose membrane. The control peptides were as follows: AML1-ETOK24 peptide (TALSPGKMSEA) and
AML1-ETOK43 peptide (LAGK LRSGDRS).
Immunoprecipitation and Western blot assays
The Flag-AE, Flag-AE-∆NHR1 (aa245-436), Flag-AE-∆NHR2, Flag-ETO, Flag-ETO-∆NHR1 and Flag-ETO-∆NHR2 cDNAs were cotransfected into 80% confluent 293T cells using the FuGene 6 reagent. After 36 hours the cells were lysed in RIPA buffer with 1 mM DTT and DNAse I 1 µg/mL and a proteinase inhibitor cocktail (Roche), and incubated on ice for 30 minutes. Nuclear extracts were prepared to examine the endogenous protein-protein interactions. Anti-Flag agarose (Sigma), anti-HA agarose (Pierce) or protein A/G agarose (Santa Cruz) was used in the immunoprecipitation assays.
For western blot assays, protein samples were separated by electrophoresis on denaturing 3-8% or 4-12% premade polyacrylamide gels (Invitrogen) and blotted to PVDF membranes (Millipore).
Chromatin Immunoprecipitation (ChIP) Assays
Chromatin immunoprecipitation assays were performed using an antigen-purified anti-ETO antibody and a p300 antibody (Santa Cruz). 8x10 7 Kasumi-1 cells were used for each ChIP reaction. Kasumi-1 cells (which do not express ETO protein) were first dual cross-linked with 2 mM Disuccinimidyl glutarate and 1% formaldehyde and then lysed with buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1). The cell lysates were subjected to sonication, diluted in buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.1, 167 mM NaCl) and then immunoprecipitated using the indicated antibodies. Subsequently, the immunoprecipiated DNA was purified, and quantified by Real-Time PCR at specific genomic loci within the genes of interest (the primer sequences are available upon request). Quantitative results are represented as percentages of the total input.
ChIP-seq libraries were constructed following the Illumina protocol. Briefly, end-repair, "A" addition, and adaptor ligation were performed on 10 ng ChIP or Input DNA.
Adaptor-ligated DNA with a size between 200 to 300 bp was selected and amplified to generate a DNA library suitable for sequencing. 8 pM of the sequencing library was applied to Illumina Single-Read flowcells for cluster generation on cBot. Finally, the clusters were sequenced on the Illumina Genome Analyzer II to generate 36-bp short sequence reads, which were aligned to the human reference genome (hg18) using ELAND. After filtering clonal reads, uniquely aligned reads were then used to perform peak-calling by ChIPseeqer (http://icb.med.cornell.edu/wiki/index.php/Elementolab/).
Fetal liver transplantation
Fetal liver cells were harvested from E14.5 embryos. Subsequently, LSK (Lin -, Sca1 + , Ckit + ) cells were sorted and infected with retroviruses by spinoculation. The fetal liver
HSPCs were cultured in X-VIVO medium with 10 ng/ml IL-3, 10 ng/ml IL-6 and 100 ng/ml stem cell factor (Peprotech). The efficiency of transduction by the various MIGR1-based viruses was determined on the basis of GFP positivity using flow cytometry. The C57Bl/6.SJL recipient mice were lethally irradiated with 950 cGy, given in a split dose separated by 4 hours. The transduced fetal liver cells were transplanted into recipient mice by tail-vein injection.
Knocking down p300 in the t(8;21) + Kasumi-1 leukemia cell line
The lentivirus expressing shRNAs against p300, or a control shRNA (scrambled shRNA), was produced in 293T cells. To stably knock down the expression of p300 in Kasumi-1 cells, we used 1 µg/ml puromycin (Sigma) to select the positive clones. 72 hours after the puromycin selection, RNA and protein were collected for the Q-PCR and Western blotting experiments. The sequences for the p300 directed shRNAs are available upon request.
Lys-CoA-Tat or C646 treatment of primary leukemia cells and leukemia cell lines
The Lys-CoA-Tat, DDDD-Tat, C646 and C37 compounds were provided by P.A.C. or were synthesized by the organic synthesis core facility (MSKCC 
Peptide pull-down assays
Acetylated and nonacetylated peptides (used for antibody development) were conjugated to SulfoLink agarose (Pierce). For each pull-down reaction, 100 μg of nuclear extract from K562 cells were used with 10 μg of peptide-bound beads in the binding buffer (150 mM NaCl and 20 mM HEPES pH 7.9). After rotating overnight at 4°C, the beads were washed five times with binding buffer, and five times with 300 mM NaCl and 20 mM HEPES (pH 7.9) buffer, plus protease inhibitors. The bound protein was then eluted with 500 mM NaCl and 20 mM HEPES (pH 7.9) buffer, and analyzed by Western blot analysis.
Electrophoretic mobility shift assays (EMSA)
N-terminal Flag-tagged AE, AEK24R, AEK43R or AEK24,43R proteins were prepared as nuclear extracts from 293T cells transfected with each expression construct, using the empty vector MIGR1 as a control. The oligonucleotide probes contained sequences from the human separase gene; wild type (Wt): (5'-GAGTGGTGTGGTAGTGCGGTCGGGG-3') or the AML1 binding site mutant (Mu) (5'-GAGTGGTGTGGTAGTGCTAGCGGGG-3'). The Wt seperase probe was labeled with biotin. The incubation mixtures were separated by 6% non-denaturing PAGE gel and the bands were detected by LightShift Chemiluminescent EMSA Kit (Pierce).
MTT reduction assay
Cells were treated with p300 inhibitors at different concentrations in a 96-well plate. After 72 hours, 0.1 mg MTT was added to each well. The samples were incubated at 37°C
for 4 hours and the absorbance was measured at 570 nm by spectrophotometry.
Statistical Analysis
Assays were set up in triplicates and the results expressed as the mean ± SD. Statistical analyses were performed using Student's t-test. Survival functions were estimated using the Kaplan-Meier method and compared by the log-rank test. 
